Search / Trial NCT06228716

Education With Hybrid Simulation Method in Patients Administering Subcutaneous Biological Drugs

Launched by İLAYDA TÜRKOĞLU · Jan 18, 2024

Trial Information

Current as of October 07, 2024

Completed

Keywords

Self Administratation Anxiety Subcutaneous Injection Biological Therapy Simulation Training

Description

A poor self-injection experience can lead to undesirable treatment outcomes. However, increasing morbidity and mortality rates are closely related to non-adherence to treatment. Undesirable results due to non-compliance with treatment lead to more visits to emergency services, prolongation of inpatient treatments and increased surgical interventions, thus increasing the workload and costs of health services. In addition, patients who cannot receive repeated and effective training on subcutaneous injection application cause them to experience anxiety about subcutaneous drug administration on...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Being between the ages of 18-50,
  • * Residing in Istanbul,
  • * Their family/relatives are not using medication in subcutaneous injection form,
  • * Receiving injection training for the first time,
  • * First time injection application,
  • * Using biological medication for the first time,
  • * Using subcutaneous biological medication for the first time,
  • * The requested subcutaneous biological drug must be in pen form,
  • * The drug administration dose should be once every 2 weeks (1/14),
  • * Being open to communication and cooperation,
  • * No experience of injecting any living creature (human or animal),
  • * There is no cognitive, perceptual, or physical disability that would hinder the ability to administer self-injection,
  • * Volunteering to participate in the research.
  • Exclusion Criteria:
  • * Leaving the study at any stage of the research process,
  • * Not participating in the training and evaluations included in the research,
  • * Having any local or systemic infectious disease at any stage of the research process.

About İlayda Türkoğlu

İlayda Türkoğlu is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in clinical operations and regulatory affairs, she excels in overseeing the design, implementation, and management of clinical trials across various therapeutic areas. İlayda is passionate about fostering collaboration among multidisciplinary teams to ensure adherence to ethical standards and regulatory compliance, while also prioritizing participant safety and data integrity. Her leadership and innovative approach contribute significantly to the successful execution of clinical studies, ultimately aiming to bring new treatments to market efficiently and effectively.

Locations

üsküdar, İ̇stanbul, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0